Axalta Coating Systems (AXTA) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Apr, 2026Executive summary
Achieved record financial results in 2025, with Adjusted EBITDA of $1,128M and Adjusted Diluted EPS of $2.49, despite a 3% decline in net sales due to lower volumes in North America and macro headwinds.
Delivered strong operational execution, margin performance, and over $300M in cumulative variable cost savings from 2023 to 2025.
Announced a merger of equals with AkzoNobel, expected to create a global leader in performance coatings with $17B in combined net sales and significant synergy potential.
Financial highlights
Q4 2025 net sales were $1,262M, down 4% year-over-year; Adjusted EBITDA was $272M (21.5% margin, up 50 bps YoY).
Full-year 2025 net sales were $5,117M, down 3%; Adjusted EBITDA was $1,128M (22.0% margin, up 80 bps YoY); Adjusted Diluted EPS was $2.49, up 6%.
Free cash flow reached a record $466M, up over $300M from 2022; Q4 free cash flow was $290M, up 64%.
Q4 net income was $60M, down from $137M last year, impacted by higher tax expense and merger-related costs; full-year net income was $379M.
Outlook and guidance
2026 expected to start slow, with recovery building in the second half, driven by catalysts like interest rate reductions and higher vehicle prices.
Full-year 2026 revenue expected to grow low single digits; Adjusted EBITDA guided to $1,140M–$1,170M; Adjusted Diluted EPS to $2.55–$2.70; free cash flow projected above $500M.
Capital expenditures projected at $180M–$200M; net leverage expected below 2x by year-end.
Latest events from Axalta Coating Systems
- Record Q2 sales, earnings, and cash flow set the stage for the AkzoNobel merger.AXTA
Q2 2026 - Shareholders to vote on transformative Axalta merger as financials remain stable amid divestments.AXTA
Proxy filing - Shareholders to vote on a transformative $25B all-stock merger creating a global coatings leader.AXTA
Proxy filing - Q1 2026 beat guidance with strong cash flow, Mobility growth, and AkzoNobel merger progress.AXTA
Q1 2026 - Record 2025 results, robust governance, and a pending AkzoNobel merger highlight this proxy.AXTA
Proxy filing - Director elections, auditor appointment, and executive pay are up for shareholder vote.AXTA
Proxy filing - Record Q3 sales and margin expansion led to raised 2024 guidance and strong growth outlook.AXTA
Q3 2024 - Record Q2 sales, margin gains, and raised 2024 guidance driven by robust segment growth.AXTA
Q2 2024 - Record 2024 results, margin expansion, and strong 2025 outlook despite macro risks.AXTA
Q4 2024